TABLE 1.

Characteristics of COVID-19 patients.

	HDIVC (n = 55)	Control (n = 55)	P Value
Age, median (IQR), y	36 (31–47)	36 (31–46)	0.96
Sex (male, n)	33	35	0.69
Weight, median (IQR), kg	70 (58–80)	65 (55–76)	0.26
Interval from first symptom to admission, median (IQR), days	4 (2–6)	3 (2–7)	0.65
Symptoms on Day 0
Fever (n)	34	43	0.06
Dry cough (n)	27	32	0.33
Diarrhea (n)	6	4	0.51
Olfactory dysfunction (n)	3	0	0.07
Gustatory dysfunction (n)	2	0	0.15
Co-existing disease
Hypertension (n)	1	6	0.05
Diabetes (n)	3	4	0.69
Contemporary treatments, n
Antiviral (n)	52	54	0.31
Antibiotic (n)	12	20	0.06
Low molecular heparin (n)	16	10	0.44
Glucocorticoid (n)	2	5	0.24

HDIVC, high dose intravenous vitamin C; IQR, interquartile range; Day 0, the day on admission. P, HDIVC vs control group.